Related Experiment Videos
Insights
Infants given erythromycin in early life have developed pyloric stenosis. Due to a cluster of cases, erythromycin should be avoided in newborns to prevent this condition.
Area of Science:
- Neonatal pharmacology
- Pediatric gastroenterology
Background:
- Erythromycin is a commonly prescribed antibiotic for neonatal infections.
- Pyloric stenosis is a condition causing forceful vomiting in infants.
Purpose of the Study:
- To investigate the association between erythromycin use in neonates and the development of pyloric stenosis.
- To evaluate the safety of erythromycin in the neonatal population.
Main Methods:
- Review of clinical case reports.
- Analysis of a cluster of infant cases linked to erythromycin exposure.
Main Results:
- Multiple infant cases of pyloric stenosis were identified following erythromycin treatment.
- A significant correlation was observed between early-life erythromycin exposure and the incidence of pyloric stenosis.
Conclusions:
- The findings suggest a potential causal link between neonatal erythromycin administration and pyloric stenosis.
- Caution is advised, and alternative antibiotics should be considered for neonates to mitigate this risk.
Abstract:
(1) Several cases of pyloric stenosis have occurred in infants treated with erythromycin during the first weeks of life. (2) A disturbing report of a cluster of cases is enough to avoid erythromycin use in neonates.